Found: 21
Select item for more details and to access through your institution.
The role of thioredoxin system in cancer: strategy for cancer therapy.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Aspects of vincristine-induced neuropathy in hematologic malignancies: a systematic review.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Cytochrome P450 3A4, 3A5, and 2C8 expression in breast, prostate, lung, endometrial, and ovarian tumors: relevance for resistance to taxanes.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Application of time-dependent modeling for the exposure-efficacy analysis of ceritinib in untreated ALK-rearranged advanced NSCLC patients.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Electrophysiologic evaluation of facial nerve functions after oxaliplatin treatment.
- Published in:
- 2019
- By:
- Publication type:
- journal article
BRAF mutation status might contribute an effect on both disease-free and overall survival in stage III cutaneous melanomas treated with intermediate dose interferon-alpha.
- Published in:
- 2019
- By:
- Publication type:
- journal article
In vitro evaluation of FL118 and 9-Q20 cytotoxicity and cellular uptake in 2D and 3D different cell models.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Pharmacokinetic and exposure-response analysis of pertuzumab in patients with HER2-positive metastatic gastric or gastroesophageal junction cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Identification of dinactin, a macrolide antibiotic, as a natural product-based small molecule targeting Wnt/β-catenin signaling pathway in cancer cells.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Efficacy and safety of 4-weekly cabazitaxel for castration-resistant prostate cancer: a multi-institutional study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A phase 1b, multicenter, open-label, dose-finding study of eribulin in combination with carboplatin in advanced solid tumors and non-small cell lung cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Spatial memory deficits in mice induced by chemotherapeutic agents are prevented by acetylcholinesterase inhibitors.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Genistein combined with FOLFOX or FOLFOX-Bevacizumab for the treatment of metastatic colorectal cancer: phase I/II pilot study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Incidence of and risk factors for cardiotoxicity after fluorouracil-based chemotherapy in locally advanced or metastatic gastric cancer patients.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A high AR:ERα or PDEF:ERα ratio predicts a sub-optimal response to tamoxifen therapy in ERα-positive breast cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Assessment of the effect of erdafitinib on cardiac safety: analysis of ECGs and exposure-QTc in patients with advanced or refractory solid tumors.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Is pathologic tumor regression grade after neo-adjuvant chemotherapy a promising prognostic indicator for patients with locally advanced gastric cancer? A cohort study evaluating tumor regression response.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The efficacy and safety of nab paclitaxel plus gemcitabine in elderly patients over 75 years with unresectable pancreatic cancer compared with younger patients.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Intrapericardial carboplatin in the management of malignant pericardial effusion in breast cancer: a pilot study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Rituximab dosing in hematological malignancies: an old question, revisited.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Correction to: Population pharmacokinetics of PF‑05280014 (a trastuzumab biosimilar) and reference trastuzumab (Herceptin<sup>®</sup>) in patients with HER2‑positive metastatic breast cancer.
- Published in:
- 2019
- By:
- Publication type:
- corrected article